◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksS › SYNT

Synthomer plc (SYNT) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Basic Materials · Specialty Chemicals · DATA UPDATED 2026-08-16

Synthomer plc (SYNT) operates in the Specialty Chemicals industry and is headquartered in London, United Kingdom with about 3,800 employees. Its market capitalization is roughly £166 million. In the fiscal year ended 2025-12-31, SYNT reported £1.7B in revenue and (£157M) in net income.

Synthomer plc manufactures and supplies specialised polymers and ingredients for coatings, construction, adhesives, and health and protection sectors.

Interactive charts & full statements →

SYNT Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue£1.7B£1.9B£1.9B£2.3B
Gross Profit£307M£414M£665M
Operating Income (EBIT)£1.7B£1.9B(£40M)£123M
Net Income(£157M)(£73M)(£67M)(£32M)

GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SYNT Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid(£100M)(£74M)

GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SYNT Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-31
Total Assets£2.3B£2.5B£2.7B£3.0B
Total Liabilities£1.4B£1.4B£1.5B£2.0B

GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SYNT viewer.

Other Companies in Specialty Chemicals

← SYNCAll “S” companiesSYPR →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.